Azusa Futatsugi ^1,2, Kota Toshimoto ¹, Takashi Yoshikado ¹, Yukio Kato ², Yuichi Sugiyama ¹ (1.Sugiyama Lab., RIKEN Innovation Center, RIKEN, Yokohama, 2.Faculty of Pharmacy, Kanazawa University, Kanazawa 920-1192)

Takeshi Matsumoto ¹, Kota Toshimoto ², Koji Chiba ³, Yuichi Sugiyama ² (1.Pharmaceutical Division, FUJIFILM Corporation, 2.Sugiyama Lab., RIKEN Innovation Center RIKEN, 3.Laboratory of Clinical Pharmacology, Yokohama University of Pharmacy)

Issey Takehara ¹, Hanano Terashima ², Takeshi Nakayama ², Takashi Yoshikado ³, Miwa Yoshida ⁴, Kenichi Furihata ⁴, Nobuaki Watanabe ¹, Kazuya Maeda ², Osamu Ando ¹, Yuichi Sugiyama ³, Hiroyuki Kusuhara ² (1.Drug Metabolism & Pharmacokinetics Research Laboratories, Daiichi Sankyo Co., Ltd., 2.Graduate School of Pharmaceutical Sciences, the University of Tokyo, Japan, 3.Sugiyama Lab., RIKEN Innovation Center, RIKEN, Yokohama, Japan, 4.P-One Clinic, Keikokai Medical Corp.)

Yukina Fukuchi ¹, Takanori Mori ¹, Ryuta Asaumi ¹, Kenichi Nunoya ¹, Haruo Imawaka ¹, Kota Toshimoto ², Seiji Miyauchi ², Yuichi Sugiyama ² (1.Ono Pharmaceutical Co., Ltd., 2.RIKEN Sugiyama Laboratory)

Saki Izumi ¹, Yoshitane Nozaki ¹, Takafumi Komori ¹, Kazuya Maeda ², Hiroyuki Kusuhara ², Yuichi Sugiyama ³ (1.Eisai Co., Ltd., 2.Graduate School of Pharmaceutical Sciences, The University of Tokyo, 3.RIKEN Innovation Center, RIKEN)

Takashi Yoshikado ¹, Kota Toshimoto ¹, Tomohisa Nakada ², Kazuaki Ikejiri ³, Kei Ogawa ², Noriko Hisanaga ², Hiroyuki Kusuhara ³, Kazuya Maeda ³, Yuichi Sugiyama ¹ (1.Sugiyama Laboratory, RIKEN Innovation Center, RIKEN, 2.DMPK Research Laboratories, Mitsubishi Tanabe Pharma Corporation, 3.Laboratory of Molecular Pharmacokinetics, Graduate School of Pharmaceutical Sciences, the University of Tokyo)